Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens
Public ClinicalTrials.gov record NCT00129194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of KP-1461 in HIV+ Adults Who Have Failed Two or More Highly Active Antiretroviral Regimens (HAART)
Study identification
- NCT ID
- NCT00129194
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Koronis Pharmaceuticals.
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- KP-1461 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2005
- Primary completion
- May 31, 2007
- Completion
- Not listed
- Last update posted
- Jan 3, 2008
Started 2005
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bach and Godofsky | Bradenton | Florida | 34205 | — |
| University of Miami | Miami | Florida | 33146 | — |
| Triple O Medical Services | West Palm Beach | Florida | 33401 | — |
| Research Centers of Via Christi | Wichita | Kansas | 67214 | — |
| Institute of Human Virology, University of Maryland | Baltimore | Maryland | 21201 | — |
| Dybedal Center for Clinical Research, Kansas City University of Medicine and Biosciences | Kansas City | Missouri | 64106-1453 | — |
| St. Michael's Medical Center | Newark | New Jersey | 07102 | — |
| AIDS Community Research Initiative of America | New York | New York | 10018 | — |
| Greenville Hospital System | Greenville | South Carolina | 29605 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00129194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2008 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00129194 live on ClinicalTrials.gov.